Expert Lectures held on Depression in Patients with Comorbidity

Depression is the most frequent psychiatric disorder and the most important cause of work incapacity in the world. This was the discussion topic of Prof Dr Abdulah Kučukalić and D.Sc. Alma Džubur Kulenović at a prominent scientific conference held in Sarajevo on 16 April 2014.

Bosnalijek, in cooperation with the Medical Chamber of Sarajevo Canton and the Masters of Pharmacy Chamber of the Federation of Bosnia and Herzegovina, organised expert scientific lectures on two topics: 1) the proper selection of selective serotonin reuptake inhibitors - SSRI - in the treatment of depressive disorders with comorbidity and 2) specifics of SSRI profiles.

On this occasion, as a renowned manufacturer with an extensive generic product range, Bosnalijek presented a new medicine contributing to the improvement of health in patients with depression and depressive anxiety disorders.

Nedim Uzunović, acting Manager of Bosnalijek, said, “In line with global trends in pharmacy and medicine, this year we have focused our efforts on the development of medicines with effect on the central nervous system” adding “We are proud to contribute to the development of the latest pharmacotherapeutic trends, which we strive to follow and implement in the territory of Bosnia and Herzegovina”.

Depression is the most frequent psychiatric disorder and the most important cause of work incapacity in the world. It usually occurs between 25 and 40 years of age but frequently can occur earlier, even in childhood. It is believed that prior to 2025 depression will be the second most frequent disorder in men and the first in women.
April 17, 2014